Event dossier

Every Cure’s drug repurposing strategy isn't what you think, and it could change rare disease treatment

When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that challenged the traditional research model.

1 report1 sourceMar 27, 2026, 5:02 PM
FilterCNBC
Clustered coverageCNBC
Coverage timeline1
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

CNBCMar 27, 2026, 5:02 PM

Every Cure’s drug repurposing strategy isn't what you think, and it could change rare disease treatment

When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that challenged the traditional research model.

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.

El Psy Congroo Newswire